Cargando…

A novel approach of recombinant laterosporulin production using the N-SH2 domain of SHP-2

BACKGROUND: The current study was aimed at evaluating the role of the N-SH2 domain of SHP-2 as a partner protein in the expression of a toxic peptide, laterosporulin (LTS). We also investigated its effects on the formation of the disulfide bond and functional folding of the peptide in vitro. The N-S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salehzadeh, Simin, Tabatabaei, Mohammad, Derakhshandeh, Abdollah, Karbalaei-Heidari, Hamidreza, Kazemipour, Nasrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529825/ https://www.ncbi.nlm.nih.gov/pubmed/34674683 http://dx.doi.org/10.1186/s12896-021-00721-7

Ejemplares similares

Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2
por: Park, Hyunju, et al.
Publicado: (2015)

Understanding the Mechanism of Recognition of Gab2 by the N-SH2 Domain of SHP2
por: Visconti, Lorenzo, et al.
Publicado: (2020)

A novel chimeric recombinant protein PDHB-P80 of Mycoplasma agalactiae as a potential diagnostic tool
por: Akbarzadeh-Niaki, Malihe, et al.
Publicado: (2020)

Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Determining folding and binding properties of the C‐terminal SH2 domain of SHP2
por: Nardella, Caterina, et al.
Publicado: (2021)

A novel fusion protein candidate for the serodiagnosis of Mycoplasma agalactiae infection
por: Akbarzadeh-Niaki, Malihe, et al.
Publicado: (2022)

Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10
por: Baindara, Piyush, et al.
Publicado: (2017)

Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft
por: Guvench, Olgun, et al.
Publicado: (2007)

Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus sp. Strain GI-9
por: Singh, Pradip Kumar, et al.
Publicado: (2012)

(1)H, (13)C, (15)N chemical shift assignments of SHP2 SH2 domains in complex with PD-1 immune-tyrosine motifs
por: Marasco, Michelangelo, et al.
Publicado: (2020)

SH2 Domain-Containing Phosphatase-SHP2 Attenuates Fibrotic Responses through Negative Regulation of Mitochondrial Metabolism in Lung Fibroblasts
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

SH2 and SH3 domains
por: Pawson, Tony
Publicado: (1992)

Negative Regulation of Ros Receptor Tyrosine Kinase Signaling: An Epithelial Function of the Sh2 Domain Protein Tyrosine Phosphatase Shp-1
por: Keilhack, Heike, et al.
Publicado: (2001)

Hematopoietic cell phosphatase, SHP-1, is constitutively associated with the SH2 domain-containing leukocyte protein, SLP-76, in B cells
Publicado: (1996)

SH2db, an information system for the SH2 domain
por: Bajusz, Dávid, et al.
Publicado: (2023)

Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal
por: Maeda, Akito, et al.
Publicado: (1998)

Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase
por: Anselmi, Massimiliano, et al.
Publicado: (2020)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study
por: Bellacchio, Emanuele
Publicado: (2022)

Novel Roles of SH2 and SH3 Domains in Lipid Binding
por: Sipeki, Szabolcs, et al.
Publicado: (2021)

The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain
por: van Vlimmeren, Anne E., et al.
Publicado: (2023)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
por: Linossi, Edmond M., et al.
Publicado: (2021)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Functions of Shp2 in cancer
por: Zhang, Jie, et al.
Publicado: (2015)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

Negative regulation of the SH2-homology-containing protein-tyrosine phosphatase-1 (Shp-1) P2 promoter by the HTLV-1 tax oncoprotein
por: Cheng, Jihua, et al.
Publicado: (2006)

Author Correction: Discovery of an exosite on the SOCS2-SH2 domain that enhances SH2 binding to phosphorylated ligands
por: Linossi, Edmond M., et al.
Publicado: (2023)

SH2 Domain Binding: Diverse FLVRs of Partnership
por: Jaber Chehayeb, Rachel, et al.
Publicado: (2020)

SH2 Domains: Folding, Binding and Therapeutical Approaches
por: Diop, Awa, et al.
Publicado: (2022)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Skeletal malformation and the SHP-2 pathway
Publicado: (2011)

Deltacron is a recombinant variant of SARS-CoV-2 but not a laboratory mistake
por: Karbalaei, Mohsen, et al.
Publicado: (2022)

The Allosteric Site on SHP2’s Protein Tyrosine Phosphatase Domain is Targetable with Druglike Small Molecules
por: Marsh-Armstrong, Brennan, et al.
Publicado: (2018)

Plasma miR‐21 as a potential predictor in prediabetic individuals with a positive family history of type 2 diabetes mellitus
por: Yazdanpanah, Zakieh, et al.
Publicado: (2022)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xu, Xiaozheng, et al.
Publicado: (2021)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6ue2485d54hboqqqld9dv58q7k